The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting
Open accessAbstract
Collecting economic data at the same time as evidence of effectiveness maximises the information available for analysis but requires proper consideration at the design stage
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Sterne, J. A. C., White, I. R., Carlin, J. B., Spratt, M., Royston, P., Kenward, M. G., Wood, A. M., & Carpenter, J. R. (2009) · BMJ · doi:10.1136/bmj.b2393 · Cited by 7,299
EuroQol: the current state of play
Brooks, R. (1996) · Health Policy · doi:10.1016/0168-8510(96)00822-6 · Cited by 5,815
The estimation of a preference-based measure of health from the SF-36
Brazier, J., Roberts, J., & Deverill, M. (2002) · Journal of Health Economics · doi:10.1016/s0167-6296(01)00130-8 · Cited by 3,026
Measuring and Valuing Health Benefits for Economic Evaluation
Brazier, J., Ratcliffe, J., Saloman, J., & Tsuchiya, A. (2016) · Oxford Medicine Online · doi:10.1093/med/9780198725923.001.0001 · Cited by 1,050
Manca, A., Hawkins, N., & Sculpher, M. J. (2005) · Health Economics · doi:10.1002/hec.944 · Cited by 1,024
Methods for the economic evaluation of health care programmes, 3rd ed
Adamiak, G. T. (2006) · PubMed Central · Cited by 953
Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions
Fenwick, E., O'Brien, B. J., & Briggs, A. (2004) · Health Economics · doi:10.1002/hec.903 · Cited by 943
Economic Evaluation in Clinical Trials
Glick, H. A., Doshi, J. A., Sonnad, S. S., & Polsky, D. (2014) · Oxford University Press eBooks · doi:10.1093/med/9780199685028.001.0001 · Cited by 910
Claxton, K. (1999) · Journal of Health Economics · doi:10.1016/s0167-6296(98)00039-3 · Cited by 889
Utilities and Quality-Adjusted Life Years
Torrance, G. W., & Feeny, D. (1989) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300008461 · Cited by 818
How should cost data in pragmatic randomised trials be analysed?
Thompson, S. G. (2000) · BMJ · doi:10.1136/bmj.320.7243.1197 · Cited by 772
Review of statistical methods for analysing healthcare resources and costs
Mihaylova, B., Briggs, A., O'Hagan, A., & Thompson, S. G. (2011) · Health Economics · doi:10.1002/hec.1653 · Cited by 767 · cited 1×
“Although cost data are often right skewed because a few patients use very high amounts of resource, producing a distribution that may violate the assumptions of standard statistical tests, it is not clear that the many alternative approaches suggested, such as bootstrapping, provide more reliable test results.”
BackgroundRamsey, S., Willke, R., Briggs, A., Brown, R., Buxton, M., Chawla, A., Cook, J., Glick, H., Liljas, B., Petitti, D., et al. (2005) · Value in Health · doi:10.1111/j.1524-4733.2005.00045.x · Cited by 720
Devlin, N., & Parkin, D. (2004) · Health Economics · doi:10.1002/hec.864 · Cited by 709
Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold
Grosse, S. D. (2008) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.8.2.165 · Cited by 637
The CE Plane: A Graphic Representation of Cost-Effectiveness
Black, W. C. (1990) · Medical Decision Making · doi:10.1177/0272989x9001000308 · Cited by 581
Valuing the ICECAP capability index for older people
Coast, J., Flynn, T. N., Natarajan, L., Sproston, K., Lewis, J., Louviere, J. J., & Peters, T. J. (2008) · Social Science & Medicine · doi:10.1016/j.socscimed.2008.05.015 · Cited by 558
Multi-Attribute Preference Functions: Health Utilities Index
Torrance, G. W., Furlong, W., Feeny, D., & Boyle, M. (1995) · PharmacoEconomics · doi:10.2165/00019053-199507060-00005 · Cited by 533
Mark, D. B., Hlatky, M. A., Califf, R. M., Naylor, C. D., Lee, K. L., Armstrong, P. W., Barbash, G., White, H., Simoons, M. L., Nelson, C. L., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505253322106 · Cited by 521
Brazier, J. E., Yang, Y., Tsuchiya, A., & Rowen, D. L. (2010) · The European Journal of Health Economics · doi:10.1007/s10198-009-0168-z · Cited by 516
Measuring and Valuing Health Benefits for Economic Evaluation
Brazier, J. E., Ratcliffe, J., Salomon, J. A., & Tsuchiya, A. (2007) · OUP Catalogue · Cited by 439
Whither trial‐based economic evaluation for health care decision making?
Sculpher, M. J., Claxton, K., Drummond, M., & McCabe, C. (2006) · Health Economics · doi:10.1002/hec.1093 · Cited by 407
Economic Evaluation in Clinical Trials
Glick, H. A., Doshi, J. A., Sonnad, S. S., & Polsky, D. E. (2007) · OUP Catalogue · Cited by 366
Applied Methods of Cost-effectiveness Analysis in HealthcarePreprint
Gray, A. M., Clarke, P., Wolstenholme, J. L., & Wordsworth, S. (2010) · RePEc: Research Papers in Economics · Cited by 343
Self-citationValuing health states: A comparison of methods
Dolan, P., Gudex, C., Kind, P., & Williams, A. (1996) · Journal of Health Economics · doi:10.1016/0167-6296(95)00038-0 · Cited by 335
Hewitt, C., Gilbody, S., Brealey, S., Paulden, M., Palmer, S., Mann, R., Green, J., Morrell, J., Barkham, M., Light, K., et al. (2009) · Health Technology Assessment · doi:10.3310/hta13360 · Cited by 330
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · Cited by 302
Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting
Petrou, S., & Gray, A. (2011) · BMJ · doi:10.1136/bmj.d1766 · Cited by 292
Self-citationPHARMACEUTICAL BENEFITS ADVISORY COMMITTEE
(1958) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1958.tb58406.x · Cited by 255
Drummond, M., Manca, A., & Sculpher, M. (2005) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462305050221 · Cited by 251
NICE Guide to the Methods of Technology Appraisal: Pharmaceutical Industry Perspective
Earnshaw, J., & Lewis, G. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826090-00002 · Cited by 226
Economic evaluation and clinical trials: size matters
Briggs, A. (2000) · BMJ · doi:10.1136/bmj.321.7273.1362 · Cited by 224
Optimal recall length in survey design
Clarke, P. M., Fiebig, D. G., & Gerdtham, U.-G. (2008) · Journal of Health Economics · doi:10.1016/j.jhealeco.2008.05.012 · Cited by 204
Clarke, P. M., Gray, A. M., Briggs, A., Stevens, R. J., Matthews, D. R., Holman, R. R., & (UKPDS), O. B. O. T. U. P. D. S. (2005) · Diabetologia · doi:10.1007/s00125-005-1717-3 · Cited by 155
Self-citationZethraeus, N., Johannesson, M., nsson, B. J., L�thgren, M., & Tambour, M. (2003) · PharmacoEconomics · doi:10.2165/00019053-200321010-00003 · Cited by 124
O’Sullivan, A. K., Thompson, D., & Drummond, M. (2005) · Value in Health · doi:10.1111/j.1524-4733.2005.03065.x · Cited by 108
Scottish Medicines Consortium.
KOHLI, H. S. (2005) · PubMed · Cited by 108
Rapple, B. A. (1994) · Education Policy Analysis Archives · doi:10.14507/epaa.v2n1.1994 · Cited by 103
Petrou, S., Bischof, M., Bennett, C. C., Elbourne, D. R., Field, D., & McNally, H. (2006) · PEDIATRICS · doi:10.1542/peds.2005-1150 · Cited by 102
Self-citationRidyard, C. H., & Hughes, D. A. (2010) · Value in Health · doi:10.1111/j.1524-4733.2010.00788.x · Cited by 96
Simon, J., Gray, A., Duley, L., & Magpie Trial Collaborative Group (2005) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2005.00785.x · Cited by 94
Self-citationPower and Sample Size Calculations for Stochastic Cost-Effectiveness Analysis
Briggs, A. H., & Gray, A. M. (1998) · Medical Decision Making · doi:10.1177/0272989x98018002s10 · Cited by 87
Self-citationWilliamson, I. G., Benge, S., Barton, S. J., Petrou, S., Letley, L. H., Fasey, N., Abangma, G., Dakin, H., & Little, P. S. (2009) · Health Technology Assessment · doi:10.3310/hta13370 · Cited by 66
Self-citationTreatment of Early-Stage Breast Cancer in the Elderly
Carter, K. J., Ritchey, N. P., Castro, F., Caccamo, L. P., Kessler, E., Erickson, B. A., & Gawdyda, L. (1998) · Medical Decision Making · doi:10.1177/0272989x9801800210 · Cited by 56
Cost-effectiveness as an outcome in randomized clinical trials
Hlatky, M. A., Owens, D. K., & Sanders, G. D. (2006) · Clinical Trials · doi:10.1177/1740774506073105 · Cited by 53
Dakin, H., Petrou, S., Haggard, M. P., Benge, S., & Williamson, I. G. (2009) · Quality of Life Research · doi:10.1007/s11136-009-9558-z · Cited by 48
Self-citationThe Problem of Protocol Driven Costs in Pharmacoeconomic Analysis
Coyle, D., & Lee, K. M. (1998) · PharmacoEconomics · doi:10.2165/00019053-199814040-00003 · Cited by 42
Discounting in decision making: the consistency argument revisited empirically
Brouwer, W. B. F. (2003) · Health Policy · doi:10.1016/s0168-8510(03)00115-5 · Cited by 25
Update on statistical power and sample size assessments for cost-effectiveness studies
Gardiner, J. C., Sirbu, C. M., & Rahbar, M. H. (2004) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.4.1.89 · Cited by 16
Cited by
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., & Loder, E. (2013) · Value in Health · doi:10.1016/j.jval.2013.02.002 · Cited by 1,998
Self-citationConsolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., Loder, E., et al. (2013) · BMJ · doi:10.1136/bmj.f1049 · Cited by 1,776
Self-citationA Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy
Hajek, P., Phillips-Waller, A., Przulj, D., Pesola, F., Myers Smith, K., Bisal, N., Li, J., Parrott, S., Sasieni, P., Dawkins, L., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1808779 · Cited by 1,421
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Value in Health · doi:10.1016/j.jval.2021.11.1351 · Cited by 1,095
Self-citationA catalogue of reporting guidelines for health research
Simera, I., Moher, D., Hoey, J., Schulz, K. F., & Altman, D. G. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02234.x · Cited by 1,047
Metadata
- Authors
- Petrou, S., & Gray, A.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2011-04-07
- Volume
- 342
- Issue
- apr07 2
- Pages
- d1548-d1548
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W1997336301
- Cited by
- 318
- References
- 51
- FWCI
- 47.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.